MPM Capital

Clinical stage pharmaceutical company for pulmonary disorders Previously developed new treatments for metabolic conditions Cancer and inflammatory disease therapeutic company Orally-delivered protein therapeutics to treat metabolic diseases Developing drugs for autoimmune diseases Previously developed implants to treat spine disorders Previously focused on molecular design Improving the diagnosis of high-risk medical conditions Aktis Oncology is a biotechnology company pioneering targeted radiopharmaceuticals Developing novel treatments for asthma Specialized in dermatological creams and gels First-in-class target for the treatment of neuropathic pain A discovery stage company focused on developing fibrosis treatments Developing a transformative therapy for heart failure novel immunotherapies for oncology and blood-related disorders Developing innovative treatments for patients with CNS disorders Development and manufacturing of gene therapies Developed and commercialized therapeutics for autoimmune diseases Manufactures medical devices for cardiac care

Developing oral drugs that were previously only available by injection Modernize clinical trials with eSource & patient engagement tools Chemogenetic neuromodulation platform to treat neurological disorders

Developing novel therapeutics for liver diseases Developing novel antibodies for cancer immunotherapy Licensing of therapeutic products for cardiopulmonary diseases Creating high-value cancer therapies using modern-day portfolio manage DigiTx Partners is a digital health investment formed in partnership with Astellas Pharma developing a new class of biosimilar products Developing a pipeline of RNA-based therapeutics for neuromuscular disorders